ClinicalTrials.gg
CompletedNCT07687329Updated Jul 7, 2026

Direct vs Indirect In-House Clear Aligners vs Fixed Appliances in Orthodontic Treatment

An interventional study of Direct In-House Clear Aligners and Indirect In-House Clear Aligners in Malocclusion, Angle Class I, sponsored by TC Erciyes University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 12 Years to 30 Years. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by TC Erciyes University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Feb 2024, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
12 Years to 30 Years
Sex
All
01

Study summary

Clear aligner therapy has become increasingly popular as an esthetic alternative to conventional braces in orthodontic treatment. While clear aligners are traditionally manufactured by commercial laboratories using a thermoforming technique, recent advances in 3D printing technology now allow clinicians to produce aligners directly in their own clinic, either by printing the aligner itself (direct method) or by printing a model and then thermoforming the aligner over it (indirect method)." "This study compares three approaches to orthodontic treatment in patients with mild to moderate dental crowding who do not require tooth extraction: clear aligners produced directly in-house using 3D printing with a shape-memory resin, clear aligners produced indirectly in-house using a 3D-printed model and thermoforming, and conventional fixed orthodontic treatment with metal brackets and wires." "A total of 36 patients aged 12 to 30 years were randomly assigned to one of these three treatment groups, and 33 patients completed the study. Treatment quality was evaluated using the American Board of Orthodontics Objective Grading System (ABO-OGS), an objective scoring method based on dental models obtained at the end of treatment. The total duration of treatment, from the start of active treatment to its completion, was also compared among the three groups." "The findings of this study may help clinicians and patients better understand the advantages and limitations of in-house clear aligner production compared to conventional fixed appliances, particularly regarding treatment efficiency and duration.

02

Conditions studied

  • Malocclusion, Angle Class I

Keywords

  • Clear aligners
  • Fixed orthodontic appliance
  • 3D Printing
  • In-House Aligners
  • Orthodontic Treatmen Duration
  • ABO Objective Grading System
03

In context

Malocclusion, Angle Class I

35 studies on the registry are indexed under Malocclusion, Angle Class I; 10 are open to participants now.

This study's enrollment of 36 is above the median of 32 across 31 interventional studies indexed under Malocclusion, Angle Class I.

Browse Malocclusion, Angle Class I studies →

Lead sponsor

TC Erciyes University is the lead sponsor of 349 studies on the registry; 74 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of permanent dentition (no primary teeth remaining)
  • Non-extraction orthodontic treatment plan
  • Age between 12 and 30 years
  • Mild to moderate dental crowding (0-6 mm)
  • Skeletal Class I classification (ANB: 2±2°)
  • Normal vertical growth direction (Sn-GoGn: 32±6°)
  • No congenital tooth agenesis (excluding third molars)
  • No atypical tooth shapes
  • No extracted permanent teeth
  • No dental caries
  • Good oral hygiene
  • Healthy periodontal tissues

Exclusion criteria

Exclusion Criteria:

  • Presence of craniofacial anomalies
  • Systemic disease or condition
  • Previous fixed orthodontic treatment
  • History of allergy to dental materials
  • History of xerostomia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Group A ( Direct - In-House)

    Participants received clear aligners manufactured directly by the clinician using 3D printing with a shape-memory resin (Tera Harz TC-85, Graphy Inc., Seoul, Korea).

    Device: Direct In-House Clear Aligners

  • Experimental
    Group B ( Indirect - In-House)

    Participants received clear aligners manufactured indirectly by the clinician via 3D-printed models followed by thermoforming with CA Pro+ sheets (SCHEU-DENTAL GmbH, Iserlohn, Germany).

    Device: Indirect In-House Clear Aligners

  • Active comparator
    Group C (Fixed Orthodontic Treatment)

    Participants received conventional fixed orthodontic treatment with metal brackets (AO Mini Master Roth 018).

    Device: Fixed Orthodontic Appliances

Interventions

  • DeviceDirect In-House Clear Aligners

    Clear aligners fabricated directly by the clinician using a stereolithography (SLA) 3D printer (Asiga MAX UV) with a shape-memory resin (Tera Harz TC-85, Graphy Inc., Seoul, Korea). The shell of the aligner was designed digitally using Direct Aligner Designer software and printed directly, without the need for a physical model. Printed aligners were post-processed by centrifugation to remove excess resin, followed by UV light curing.

  • DeviceIndirect In-House Clear Aligners

    Clear aligners fabricated indirectly by the clinician via 3D-printed dental models (Asiga MAX UV printer) followed by thermoforming using CA Pro+ sheets (0.75 x 120 mm, SCHEU-DENTAL GmbH, Iserlohn, Germany) with a pressure-forming machine (MINISTAR S). The thermoformed aligners were trimmed from the printed model after shaping.

  • DeviceFixed Orthodontic Appliances

    Conventional fixed orthodontic treatment using metal brackets (AO, Mini Master Roth 018, ) bonded to the upper and lower dental arches with stainless steel archwires.

06

What researchers measure

Primary outcomes

  1. Treatment Quality Assessed by the American Board of Orthodontics Objective Grading System (ABO-OGS)

    Post-treatment dental models were evaluated using the ABO Objective Grading System, which scores eight criteria: tooth alignment, marginal ridge height, buccolingual inclination, overjet, occlusal contacts, occlusal relationships, interproximal contacts, and root angulation. Lower total scores indicate better treatment quality. Scores were classified as successful (\<20), borderline (20-30), or unsuccessful (\>30).

    Time frame: From the date of treatment initiation (attachment placement or bracket bonding) until the date of treatment completion (final day of aligner use or bracket debonding), assessed up to 13 months

Secondary outcomes

  1. Total Treatment Duration

    The total duration of treatment was calculated as the time interval between treatment initiation (aligner delivery or bracket bonding) and treatment completion (final day of aligner use or bracket debonding)

    Time frame: From the date of treatment initiation (attachment placement or bracket bonding) until the date of treatment completion (final day of aligner use or bracket debonding), assessed up to 13 months

07

Study locations

1 site
  • Erciyes University, Faculty of Dentistry, Department of Orthodontics
    Kayseri, Melikgazi, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Mar 2025, 13 months.

Of 23 interventional studies with no phase under Malocclusion, Angle Class I, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 24. This study's 13 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2026
First posted
Jul 7, 2026
StartActual
Feb 15, 2024
Primary completionActual
Mar 15, 2025
CompletionActual
Mar 15, 2025
Last update
Jul 7, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07687329
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Ahmet Yağcı (PROF. DR., TC Erciyes University) — Principal investigator
First posted
Jul 7, 2026
Start date
Feb 15, 2024
Primary completion
Mar 15, 2025
Completion
Mar 15, 2025
Last update
Jul 7, 2026

Study contacts

Ahmet Yağcı, Prof. Dr.
principal investigator · Erciyes University, Faculty of Dentistry, Department of Orthodontics
Musa Göksu, DDS
study director · Erciyes University, Faculty of Dentistry, Department of Orthodontics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion